NCT00345345 2022-05-03Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte LeukemiaNational Institutes of Health Clinical Center (CC)Phase 2 Completed29 enrolled 17 charts
NCT00040846 2020-01-29Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesFred Hutchinson Cancer CenterPhase 2 Completed60 enrolled 10 charts
NCT01191749 2017-05-09Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)M.D. Anderson Cancer CenterPhase 2 Terminated7 enrolled 6 charts